CLINICAL_TRIALS
research
· 2026-04-01
Clinical Trial Update: Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder [Phase 2]
Summary
A Phase 2 study of pimavanserin for rigid-compulsive symptoms in autism spectrum disorder is currently recruiting, sponsored by the New York State Psychiatric I…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Autism Spectrum Disorder | Phase 2 | Status: RECRUITING